Search

Your search keyword '"Bunyan, Reem F."' showing total 23 results
Start Over Author "Bunyan, Reem F."
23 results on '"Bunyan, Reem F."'

1. Saudi consensus recommendations on the management of Neuromyelitis Optica Spectrum Disorders (NMOSD)

Author

Shosha, Eslam, Aljarallah, Salman A., Al Fugham, Norah, Al-Jedai, Ahmed H., Al Luqmani, Majed M., Al Malik, Yaser M., Al Mudaiheem, Hajer Y., Al Otaibi, Hessa S., Al Thekair, Faisal Y., Al Thubaiti, Ibtisam A., Al Yafeai, Rumaiza H., Ben Slimane, Nabila S., Bunyan, Reem F., Cupler, Edward J., Mubarki, Sultan M., Saeedi, Jameelah A., and Al Jumah, Mohammad A.

Published
2022
Full Text
View/download PDF

2. Saudi consensus recommendations on the management of multiple sclerosis: MS management in children and adolescents

Author

Bunyan, Reem F., AlAbdulSalam, Abdulaziz M., Albarakati, Rayan G., Al Harbi, Awad A., Alissa, Dema A., Al-Jedai, Ahmed H., AlKhawajah, Nuha M., Al Malik, Yaser M., Almejally, Mousa A., Al-Mudaiheem, Hajer Y., AlNajashi, Hind A., AlShehri, Amani A., Althubaiti, Ibtisam A., AlYafeai, Rumaiza H., Babakkor, Mohammed A., Cupler, Edward J., Ka, Mamdouh H., Saeedi, Jameelah A., Shosha, Eslam, and Al Jumah, Mohammed A.

Published
2022
Full Text
View/download PDF

3. The Saudi Critical Care Society practice guidelines on the management of COVID-19 in the ICU: Therapy section

Author

Alhazzani, Waleed, Alshahrani, Mohammed, Alshamsi, Fayez, Aljuhani, Ohoud, Eljaaly, Khalid, Hashim, Samaher, Alqahtani, Rakan, Alsaleh, Doaa, Al Duhailib, Zainab, Algethamy, Haifa, Al-Musawi, Tariq, Alshammari, Thamir, Alqarni, Abdullah, Khoujah, Danya, Tashkandi, Wail, Dahhan, Talal, Almutairi, Najla, Alserehi, Haleema A., Al-Yahya, Maytha, Al-Judaibi, Bandar, Arabi, Yaseen M., Abualenain, Jameel, Alotaibi, Jawaher M., Al bshabshe, Ali, Alharbi, Reham, Al-Hameed, Fahad, Elhazmi, Alyaa, Almaghrabi, Reem S., Almaghlouth, Fatma, Abedalthagafi, Malak, Al Khathlan, Noor, Al-Suwaidan, Faisal A., Bunyan, Reem F., Baw, Bandar, Alghamdi, Ghassan, Al Hazmi, Manal, Mandourah, Yasser, Assiri, Abdullah, Enani, Mushira, Alawi, Maha, Aljindan, Reem, Aljabbary, Ahmed, Alrbiaan, Abdullah, Algurashi, Fahd, Alsaawi, Abdulmohsen, Alenazi, Thamer H., Alsultan, Mohammed A., Alqahtani, Saleh A., Memish, Ziad, Al-Tawfiq, Jaffar A., and Al-jedai, Ahmed

Published
2022
Full Text
View/download PDF

5. Saudi Consensus Recommendations on the Management of Multiple Sclerosis: Symptom Management and Vaccination

Author

Al Thubaiti, Ibtisam A., primary, AlKhawajah, Mona M., additional, Al Fugham, Norah, additional, Alissa, Dema A., additional, Al-Jedai, Ahmed H., additional, Al Malik, Yaser M., additional, Almejally, Mousa A., additional, Al-Mudaiheem, Hajer Y., additional, Al-Omari, Bedor A., additional, AlOtaibi, Hessa S., additional, Al Yafeai, Rumaiza H., additional, Babakkor, Mohammed A., additional, Bunyan, Reem F., additional, Cupler, Edward J., additional, Hakami, Mohammed, additional, Kedah, Hanaa M., additional, Makkawi, Seraj, additional, Saeed, Leena H., additional, Saeedi, Jameelah A., additional, Shosha, Eslam, additional, and Al Jumah, Mohammed A., additional

Published
2023
Full Text
View/download PDF

6. Saudi Consensus Recommendations on the Management of Multiple Sclerosis: Diagnosis and Radiology/Imaging

Author

Saeedi, Jameelah A., primary, AlYafeai, Rumaiza H., additional, AlAbdulSalam, Abdulaziz M., additional, Al-Dihan, Abdulaziz Y., additional, AlDwaihi, Azeeza A., additional, Al Harbi, Awad A., additional, Aljadhai, Yaser I., additional, Al-Jedai, Ahmed H., additional, AlKhawajah, Nuha M., additional, Al-Luqmani, Majed M., additional, AlMalki, Abdulrahman O., additional, Al-Mudaiheem, Hajer Y., additional, AlNajashi, Hind A., additional, AlShareef, Rayan A., additional, AlShehri, Amani A., additional, AlThekair, Faisal Y., additional, Ben Slimane, Nabila S., additional, Cupler, Edward J., additional, Kalakatawi, Mamdouh H., additional, Kedah, Hanaa M., additional, Al Malik, Yaser M., additional, Althubaiti, Ibtisam A., additional, Bunyan, Reem F., additional, Shosha, Eslam, additional, and Al Jumah, Mohammed A., additional

Published
2023
Full Text
View/download PDF

7. Informing a cost-effectiveness threshold for Saudi Arabia

Author

Al-Jedai, Ahmed Hamdan, primary, Lomas, James, additional, Almudaiheem, Hajer Yousef, additional, Al-Ruthia, Yazed Sulaiman H., additional, Alghamdi, Shabab, additional, Awad, Nancy, additional, Alghamdi, Ahlam, additional, Alowairdhi, Mohammad A., additional, Alabdulkarim, Hana, additional, Almadi, Majid, additional, Bunyan, Reem F., additional, and Ochalek, Jessica, additional

Published
2023
Full Text
View/download PDF

8. Saudi Consensus Recommendations on the Management of Multiple Sclerosis: Disease-Modifying Therapies and Management of Relapses

Author

Al Malik, Yaser M., primary, Al Thubaiti, Ibtisam A., additional, AlAmmari, Maha A., additional, Al Fugham, Norah, additional, Ali, Eman N., additional, Alissa, Dema A., additional, Aljarallah, Salman A., additional, Al-Jedai, Ahmed H., additional, AlKathiri, Maeed A., additional, AlKhawajah, Mona M., additional, Almejally, Mousa A., additional, Al-Mudaiheem, Hajer Y., additional, Al Otaibi, Hessa S., additional, AlTowaijri, Ghadah H., additional, Al Yafeai, Rumaiza H., additional, Babakkor, Mohammed A., additional, Bohlega, Saeed A., additional, Bunyan, Reem F., additional, Cupler, Edward J., additional, Hakami, Mohammed, additional, Kareem, Abid M., additional, Khardaly, Amr M., additional, Makkawi, Seraj, additional, Saeed, Leena H., additional, Saeedi, Jameelah A., additional, Shosha, Eslam, additional, and Al Jumah, Mohammad A., additional

Published
2022
Full Text
View/download PDF

9. Saudi Consensus Recommendations on the Management of Multiple Sclerosis: Family Planning within the Management of MS.

Author

Al-Khawajah, Mona M., Al-Barakati, Rayan G., Al-Jedai, Ahmed H., Al-Malik, Yaser M., Al-Mudaiheem, Hajer Y., Al-Omari, Bedor A., Al-Thubaiti, Ibtisam A., Al-Yafeai, Rumaiza H., Bunyan, Reem F., Cupler, Edward J., Hakami, Mohammed, Kedah, Hanaa M., Makkawi, Seraj, Saeed, Leena H., Saeedi, Jameelah A., Shosha, Eslam, and Al-Jumah, Mohammed A.

Subjects
MULTIPLE sclerosis, GLATIRAMER acetate, BREASTFEEDING, NATALIZUMAB
Abstract

This review article addresses the complex issues faced by individuals with Multiple Sclerosis (MS) who are planning a family, becoming pregnant, or wishing to breastfeed their baby. Recommendations and guidelines were discussed and agreed upon by neurologists, neuroradiologists, nurses, and pharmacists involved in the management of MS in the Kingdom of Saudi Arabia (KSA). MS itself does not harm a pregnancy, and people with MS of childbearing age can be encouraged to enjoy family life. Family planning should be a part of the initial conversation with a newly diagnosed patient of childbearing age. Interferons and glatiramer acetate can be continued throughout pregnancy and can be administered during breastfeeding if the benefits outweigh the risks. These DMTs may be considered for a woman with well-controlled MS who is planning a pregnancy or otherwise not using contraception, according to an individualized risk-benefit analysis. The use of contraception should be maintained during the administration of other disease-modifying therapies (DMTs). Natalizumab can be administered at a reduced administration frequency to womenwith high MS disease activity up to 30 weeks gestation (this agent may induce hematological abnormalities in the fetus). Other DMTs should be withdrawn for variable periods before contraception is stopped and immediately after the discovery of a pregnancy (beware of rebound disease activity after withdrawing natalizumab or fingolimod). Resumption of treatment should not be delayed in women at risk of relapse during the postpartum period and especially in those who do not wish to breastfeed. [ABSTRACT FROM AUTHOR]

Published
2023
Full Text
View/download PDF

11. Update on the management of multiple sclerosis during the COVID-19 pandemic and post pandemic: An international consensus statement

Author

Reyes, Saúl, primary, Cunningham, Anthony L., additional, Kalincik, Tomas, additional, Havrdová, Eva Kubala, additional, Isobe, Noriko, additional, Pakpoor, Julia, additional, Airas, Laura, additional, Bunyan, Reem F., additional, van der Walt, Anneke, additional, Oh, Jiwon, additional, Mathews, Joela, additional, Mateen, Farrah J., additional, and Giovannoni, Gavin, additional

Published
2021
Full Text
View/download PDF

13. The Saudi Critical Care Society Practice Guidelines on the Management of COVID-19 in the ICU: Therapy Section

Author

Alhazzani, Waleed, primary, Alshahrani, Mohammed, additional, Alshamsi, Fayez, additional, Aljuhani, Ohoud, additional, Eljaaly, Khalid, additional, Hashim, Samaher, additional, Alqahtani, Rakan, additional, Alsaleh, Doaa, additional, Duhailib, Zainab Al, additional, Algethamy, Haifa, additional, Al-Musawi, Tariq, additional, Alshammari, Thamir, additional, Alqarni, Abdullah, additional, Khoujah, Danya, additional, Tashkandi, Wail, additional, Dahhan, Talal, additional, Almutairi, Najla, additional, Alserehi, Haleema A., additional, Al-Yahya, Maytha, additional, Al-Judaibi, Bandar, additional, Arabi, Yaseen M, additional, Abualenain, Jameel, additional, Alotaibi, Jawaher M., additional, Albshabshe, Ali, additional, Alharbi, Reham, additional, Al-Hameed, Fahad, additional, Elhazmi, Alyaa, additional, Almaghrabi, Reem S., additional, Almaghlouth, Fatma, additional, Abedalthagafi, Malak, additional, Khathlan, Noor Al, additional, Al-Suwaidan, Faisal A., additional, Bunyan, Reem F., additional, Baw, Bandar, additional, Alghamdi, Ghassan, additional, Hazmi, Manal Al, additional, Mandourah, Yasser, additional, Assiri, Abdullah, additional, Enani, Mushira, additional, Alawi, Maha, additional, Aljindan, Reem, additional, Aljabbary, Ahmed, additional, Alrbiaan, Abdullah, additional, Algurashi, Fahd, additional, Alsaawi, Abdulmohsen, additional, Alenazi, Thamer H., additional, Alsultan, Mohammed A., additional, Alqahtani, Saleh A., additional, Memish, Ziad, additional, Al-Tawfiq, Jaffar A., additional, and Al-Jedai, Ahmed, additional

Published
2021
Full Text
View/download PDF

14. Family Planning for People with Multiple Sclerosis in Saudi Arabia: an Expert Consensus

Author

Al Jumah, Mohammed, Al Malik, Yaser, AlKhawajah, Nuha M., Saeedi, Jameelah, AlThubaiti, Ibtisam, Bohlega, Saeed, Bunyan, Reem F., Cupler, Edward J., ElBoghdady, Ahmed, Hassan, Ahmed, Ali, Eman Nassim, and Clerico, Marinella

Subjects
Article Subject
Abstract

More than half of all patients with multiple sclerosis (MS) in the Kingdom of Saudi Arabia (KSA) are women of childbearing age. Raising a family is an important life goal for women in our region of the world. However, fears and misconceptions about the clinical course of relapsing-remitting MS (RRMS) and the effects of disease-modifying drugs (DMDs) on the foetus have led many women to reduce their expectations of raising a family, sometimes even to the point of avoiding pregnancy altogether. The increase in the number of DMDs available to manage RRMS and recent studies on their effects in pregnancy have broadened management options for these women. Interferon beta now has an indication in Europe for use during pregnancy (according to clinical need) and can be used during breastfeeding. Glatiramer acetate is a further possible option for women with lower levels of RRMS disease activity who are, or about to become, pregnant; natalizumab may be used up to 30 weeks in patients with higher levels of disease activity. Where possible, physicians need to support and encourage women to pursue their dream of a fulfilling family life, supported where necessary by active interventions for RRMS that are increasingly evidence based.

Published
2021
Full Text
View/download PDF

22. Neuroanesthesia management of neurosurgery of brain stem tumor requiring neurophysiology monitoring in an iMRI OT setting.

Author

Sabbagh, Abdulrahman J., Al-Yamany, Mahmoud, Bunyan, Reem F., Takrouri, Mohamad S. M., and Radwan, Sabry Mohammed

Subjects
BRAIN surgery, TUMOR surgery, BRAIN stem physiology, SURGICAL excision, NEUROPHYSIOLOGY, ADMINISTRATION of anesthetics, MAGNETIC resonance imaging, INTRAOPERATIVE monitoring
Abstract

This report describes a rare case of ventrally exophytic pontine glioma describing operative and neuroanesthesia management. The combination of intraoperative neuromonitoring was used. It constituted: Brain stem evoked responses/potentials, Motor EP: recording from cranial nerve supplied muscle, and Sensory EP: Medial/tibial. Excision of the tumor was done with intra-operative magnatic resonance imaging (iMRI), which is considered a new modality. [ABSTRACT FROM AUTHOR]

Published
2009
Full Text
View/download PDF

23. Do not treat from CIS onset: evaluate disease course and prognosis first--yes.

Author

Bunyan RF and Pittock SJ

Subjects
Demyelinating Diseases economics, Demyelinating Diseases therapy, Disease Progression, Humans, Magnetic Resonance Imaging, Prognosis, Demyelinating Diseases diagnosis
Abstract

As physicians how do we counsel our patients with clinically isolated syndrome (CIS) when they ask, 'what is the benefit of injecting disease-modifying agents (DMAs) over many years? What disability will they prevent in my future?' In this debate, we will provide three core points supporting the concept that a watchful waiting approach (annual neurological evaluation and magnetic resonance imaging of the head (with gadolinium) at least for the first few years after diagnosis) for most patients with CIS represents appropriate medical care.

Published
2012
Full Text
View/download PDF

Catalog

Books, media, physical & digital resources
See catalog results